Posted by & filed under Uncategorized.

Description: Moderna and Merck will jointly develop and sell a cancer vaccine that is personalized for individual patients, the companies announced on Wednesday.


Date: Oct 12, 2022


Questions for discussion:

  • Do you think think this collaboration is the right decision for both companies?
  • What do you think about the bump in stock price?
  • Would you be a buyer of these companies or other pharmaceuticals at this time?

Leave a Reply

Your email address will not be published. Required fields are marked *